Skip to main content
BMC Complementary and Alternative Medicine logoLink to BMC Complementary and Alternative Medicine
. 2010 Feb 16;10:7. doi: 10.1186/1472-6882-10-7

Laxative activities of Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae) leaf aqueous extract in rats

Souleymane Méité 1, Calixte Bahi 1, Dodéhé Yéo 1, Jacques Y Datté 2,#, Joseph A Djaman 1, David J N'guessan 1,✉,#
PMCID: PMC2830176  PMID: 20158903

Abstract

Background

Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae) is a shrub that is commonly used in Côte d'Ivoire (West Africa) for the treatment of constipation and as an ocytocic drug. The present study was carried out to investigate the laxative activity of Mareya micrantha in albino's Wistar rats.

Methods

Rats were divided in 5 groups of 5 animals each, first group as control, second group served as standard (sodium picosulfate) while group 3, 4 and 5 were treated with leaf aqueous extract of Mareya micrantha at doses of 100, 200 and 400 mg/kg body weight (b.w.), per os respectively. The laxative activity was determined based on the weight of the faeces matter. The effects of the leaves aqueous extract of Mareya micrantha and castor oil were also evaluated on intestinal transit, intestinal fluid accumulation and ions secretion.

Results

Phytochemicals screening of the extract revealed the presence of flavonoids, alkaloids, tannins, polyphenols, sterols and polyterpenes. The aqueous extract of Mareya micrantha applied orally (100, 200 and 400 mg/kg; p.o.), produced significant laxative activity and reduced loperamide induced constipation in dose dependant manner. The effect of the extract at 200 and 400 mg/kg (p.o.) was similar to that of reference drug sodium picosulfate (5 mg/kg, p.o). The same doses of the extract (200 and 400 mg/kg, p.o.) produced a significant increase (p < 0.01) of intestinal transit in comparison with castor oil (2 mL) (p < 0.01). Moreover, the extract induced a significant enteropooling and excretion of Cl-, Na+, K+ and Ca2+ in the intestinal fluid (p < 0.01).

Conclusions

The results showed that the aqueous extract of Mareya micrantha has a significant laxative activity and supports its traditional use in herbal medicine.

Background

Constipation is a highly prevalent, often chronic gastrointestinal disorder that affects adults [1-3]. The treatment with classic drugs did not cut, in one hand with the inadequate relief of bloating and other symptoms, and with the lack of efficacy in relieving constipation. So far, half of patients were not satisfied with the effect of laxatives on improving quality of life [4,5].

Plants have long been a very important source of drugs against several diseases including constipation. Mareya micrantha is well known in the traditional medical practice of the south of Côte d'Ivoire (West Africa) where the leaves of this plant is extracted with water and the extract is taken orally for the treatment of constipation [6]. It is commonly called "oyia" in the local language of "Attié" [6]. Mareya micrantha (Benth.), Syn. Mareya spicata (Baill), Müll. Arg. (Euphorbiaceae) is a shrub that is found in west and central Africa. The plant flourishes in tropical climate and it is commonly used in different parts of west and central Africa to treat diseases which require drastic action, such as tapeworm infections, gonorrhea and leprosy [7].

Previous studies showed that the aqueous leaf extracts of M. micrantha suppressed cardiac contractility of isolated frog and rat hearts in a concentration dependent way [8,9]. In another test, an aqueous leaf extract elicited concentration-dependent contractions of the longitudinal muscle of isolated guinea-pig ileum [10]. Leaf extracts caused hypotension in dogs, and a root extract caused paralysis of the respiratory centre in rats. The methanol and cold aqueous extracts of the leaves showed antibacterial activity against Enterobacter aerogenes, Agrobacterium tumefaciens, Bacillus subtilis, Clostridium sporogenes, Escherichia coli and Staphylococcus aureus [7]. Ethanolic leaf extracts showed low antiplasmodial activity against a chloroquine-resistant strain of Plasmodium falciparum [11].

Although quite a number of scientific investigations have been undertaken to validate the local use of this plant, there seems to be no report on the laxative activity of the leaves of the plant. The present study was planned to examine the laxative activity of the aqueous extract of Mareya micrantha leaves.

Methods

Plant material

The Mareya micrantha leaves, used for the study were collected from Mareya micrantha plants located at Akoupé (south of Côte d'Ivoire, West Africa) in June 2007. The plant was identified and authenticated by Pr AKE ASSI at the Department of Botany, University of Cocody. After identification, a voucher specimen (N°18041) was deposited at the herbarium of "Centre National de Floristique" of the University of Cocody-Abidjan.

Extraction procedure

The harvested leaves were air-dried and then reduced to powder with mortar and pestles. 80 g of the powder was extracted at a temperature of 90°C (by the process of maceration) with 2 L of distilled water. The macerated mixture was filtered and the filtrate was evaporated in a carefully regulated water bath (maintained at temperature of 90°C) to yield 4.5 g of dark solid extract. The extract was stored at a temperature of - 4°C pending the time for biological investigations.

Animals

Albinos Wistar rats weighing 150-200 g were housed and bred in the animal house of UFR-Biosciences at Cocody University in Abidjan (Côte d'Ivoire). The animals were kept in standard cages with good ventilation, free access to feeds and water.

Experimental procedures and protocols used in this study were approved by ethical committee of Health Sciences, University of Cocody-Abidjan. These guidelines were in accordance with the internationally accepted principles for laboratory use and care.

Phytochemical screening

The aqueous extract of Mareya micrantha was screened for phytochemical constituents using standard procedures of analysis [12].

Gastrointestinal motility tests

The method of Mascolo et al. [13] was used. Rats were divided into different groups of five rats each and fasted for 18 hours before the experiment. Three of the groups were then treated orally with three increasing doses (100, 200 and 400 mg/kg) of the extracts serving as the test groups. One group served as blank or negative control treated with saline (5 mL/kg, p.o.) and the last group was administered castor oil (2 mL/rat, p.o.), a laxative agent, as the positive control. After 30 min, the animals were given 1 mL of freshly prepared charcoal meal (distilled water suspension containing 10% gum acacia, 10% vegetable charcoal). Following 30 min of charcoal administration, the rats were sacrificed by cervical dislocation and the abdomen immediately cut open, to excise the whole small intestine (pylorus region to caecum). The length of the small intestine and the distance between the pylorus region and the front of the charcoal meal was measured for obtaining the charcoal transport ration or percentage.

Water and electrolyte secretion

The method of Robert et al. [14] was used. Animals of the first group received saline solution (5 mL/kg, p.o). Groups 2, 3, 4 and 5 received respectively castor oil (2 mL/rat, p.o) and increasing doses of the aqueous extract of Mareya micrantha (100, 200 and 400 mg/kg, p.o). Two hours later, the rats were sacrificed and the small intestine from the pylorus to caecum was extracted. The intestinal contents were collected by milking into a graduated tube and their volume was measured [15]. The fluid samples were analyzed for Na+, K+, Cl- and Ca2+ contrentrations using flame photometer (Elico® CL361).

Laxative activity

The method of Capasso et al. [16] was followed for this activity. Rats fasted for 12 h before the experiment were placed individually in cages lined with clean filter paper. Rats were divided in five groups with the first group acting as the control and administered saline (5 mL/kg, p.o.) that acted as the negative control. The second group received sodium picosulfate (5 mg/kg, p.o), this served as the positive control. The third, fourth and fifth groups received 100, 200 and 400 mg/kg per os of the Mareya micrantha aqueous extract. The faeces production (total number of normal as well as wet faeces) in all five groups was monitored for 16 h.

Laxative activity on loperamide induced constipation

This study was carried out, as earlier described by Takahura et al. [17]. Rats were placed individually in cages lined with clean filter paper, allowed to fast for 18 hours and divided into five groups of five animals each. The aqueous extract of Mareya micrantha (100, 200, and 400 mg/kg, p.o.) was administered per os to the first three groups of rats. One of the two remaining other group received normal saline (5 mL/kg, p.o) and served as a control. The last group received per os the standard drug sodium picosulfate (5 mg/kg). After 1 h, all the animals received Loperamide (5 mg/kg, p.o.) by gavage. The faeces production (total number of normal as well as wet faeces) in all five groups was monitored for 8 h.

Statistical analysis

Data obtained are presented as means ± standard error of mean (S.E.M.) for the number of animals in each group (n = 5). The differences between the data obtained from 'test' animal groups and the data obtained from untreated animal groups, were subjected to one-way analysis of variance (ANOVA; 95% confidence interval), followed by Dunnett's test. Values with p < 0.05 compared with the control group were considered as being significantly different.

Results

1-Phytochemical screening

The phytochemical screening with the different tests described (see material and methods) revealed the presence of alkaloids, tannins, flavonoids, polyphenols, sterols and polyterpenes.

2-Effect of the aqueous extract of M. micrantha on gastrointestinal motility

The results of gastrointestinal motility test were reported in table 1. The aqueous extract of Mareya micrantha increased propulsion of the charcoal meal through the gastrointestinal tract in a concentration dependant manner. No significant effect was observed at the dose of 100 mg/kg of the aqueous extract of Mareya micrantha, but the doses of 200 mg/kg and 400 mg/kg (p.o.) of the extract produced a significant increase in the propulsion of charcoal meal compared to control group (normal saline, 5 mL/kg, p.o.) (p < 0.01). Castor oil (2 mL/rat, p.o.) produced greater gastrointestinal motility effect than the highest dose of the extract (400 mg/kg, p.o.) used.

Table 1.

Effects of M. micrantha aqueous extract (MAR) on gastrointestinal motility in rats

Treatment Dose Percentage of distance (%)
Control 5 mL/kg 68,78 ± 4,64
Castor oil 2 mL/rat 93.71 ± 2.74***
MAR 100 mg/kg 70.54 ± 5.48
MAR 200 mg/kg 87.77 ± 1.84**
MAR 400 mg/kg 91.41 ± 2.11**

Values are expressed as mean ± S.E.M (n = 5); ** p < 0.01 compared to control group; and ***p < 0.001 compared to control group.

3-Effect on intestinal water secretion

The results of the volume of intestinal fluid analysis for control group, the extract at doses of 100, 200 and 400 mg/kg (p.o.) and castor oil (2 ml/rat, p.o.) are shown in table 2. Both doses of the extract (100 and 200 mg/kg) produced no significant effects on intestinal water secretion. However, the fluid volume of the rat intestine was significantly increased by the extract at the dose 400 mg/kg (p.o.) when compared with the untreated animals (control), which received only normal saline (p < 0.01). There was no statistical difference between castor oil (2 mL/rat, p.o.) and the extract at the dose of 400 mg/kg (p.o.).

Table 2.

Effects of M. micrantha aqueous extract (MAR) on intestinal water secretion in rats

Treatment Dose Volume of intestinal fluid(mL)
Control 5 mL/kg 0.74 ± 0.15
Castor oil 2 mL/rat 3.06 ± 0.25**
MAR 100 mg/kg 1.54 ± 0.12
MAR 200 mg/kg 1.8 ± 0.70
MAR 400 mg/kg 2.92 ± 0.58**

Values are expressed as mean ± S.E.M (n = 5); ** p < 0.01 compared to control.

4-Effect on intestinal ion secretion

The results of intestinal ion secretion test were reported in table 3. There was no significant effect with the doses 100 and 200 mg/kg (p.o.) of the extract on intestinal Na+, K+, Cl- secretion compared with control. At the dose of 400 mg/kg, the aqueous extract of Mareya micrantha increased signicantly Na+, K+ (p < 0.05), Cl- (p < 0.01) and Ca2+ (p < 0.001) secretions through the gastrointestinal tract compared with control group. A similar effect in the gastrointestinal transit of charcoal meal in rats was obtained with castor oil (2 mL/rat, p.o.).

Table 3.

Effects of M. micrantha aqueous extract on intestinal ion secretion in rats

Treatment Dose Na+(mg/L) K+(mg/L) Cl-(mg/L) Ca2+(mg/L)
Control 5 mL/kg 2.160 ± 0.27 0.196 ± 0.01 13.96 ± 1.69 0.478 ± 0.07
Castor oil 2 mL/rat 3.99 ± 0.66* 0.380 ± 0.5* 29.81 ± 2.03*** 0.782 ± 0.04**
MAR 100 mg/kg 2.288 ± 0.21 0.168 ± 0.02 15.68 ± 0.70 0.650 ± 0.06
MAR 200 mg/kg 2.566 ± 0.25 0.254 ± 0.03 19.86 ± 2.31 0.690 ± 0.02*
MAR 400 mg/kg 3.756 ± 0.50* 0.356 ± 0.06* 23.89 ± 2*** 0.748 ± 0.04**

Values are expressed as mean ± S.E.M (n = 5); p < 0.05 ** compared to control group; **p < 0.01 compared to control group; and ***p < 0.001 compared to control group.

5-Laxative activity of aqueous extract of M. micrantha

In this study, the different doses of the extract showed dose dependant increase in fecal output of rats when compared to the control group (table 4). There was no significant difference between the extract at the dose of 100 mg/kg (p.o.) and control group. The effects of Mareya micrantha at doses of 200 and 400 mg/kg (p.o.) increased significantly fecal output of rats compared to control group (p < 0.05-0.01). The effect of the extract at the dose of 400 mg/kg (p.o.) was similar to that of the standard drug sodium picosulfate (5 mg/kg, p.o.).

Table 4.

Laxative activity of aqueous extract of M. micrantha (MAR) in rats

Treatment Dose Faeces out put (g)
0-8 h 8 h-16 h
Control 5 mL/kg 0.748 ± 0.42 1.608 ± 0.65
Sodium picosulfate 5 mg/kg 5.090 ± 1.11** 5.415 ± 0.61**
MAR 100 mg/kg 0.892 ± 0.17 1.190 ± 0.28
MAR 200 mg/kg 3.703 ± 0.77* 4.733 ± 0.1.10*
MAR 400 mg/kg 4.829 ± 0.92** 5.217 ± 0.59**

Values are expressed as mean ± S.E.M (n = 5); * p < 0.05 compared to control group; and **p < 0.01 compared to control group.

6-Effect of the aqueous extract of M. micrantha on loperamide induced constipation in rats

In the loperamide-induced constipation, the aqueous extract of Mareya micrantha at the doses of 200 and 400 mg/kg (p.o.), increased the total number of faeces in a dose dependent manner, and the results were statistically significant (p < 0.05-0.01) (Table 5). There was no significant effect with the dose of 100 mg/kg (p.o.) of the extract compared with control. The reduction of the loperamide induced constipation at 400 mg/kg (p.o.) of plant extract treatment was found to be almost comparable with that of treatment by 5 mg/kg of sodium picosulfate.

Table 5.

Effect of M. micrantha aqueous extract (MAR) on loperamide induced constipation in rat

Treatment Dose Weight of faeces (g)
Control 5 mL/kg 0.938 ± 0.45
Sodium picosulfate 5 mg/kg 3.84 ± 0.62**
MAR 100 mg/kg 2.602 ± 0.33
MAR 200 mg/kg 2.806 ± 0.42*
MAR 400 mg/kg 3.507 ± 0.45**

Values are expressed as mean ± S.E.M (n = 5); * p < 0.05 compared to control group; and

**p < 0.01 compared to control group.

Discussion

The laxative activity of Mareya micrantha was studied in rats. The results showed that an oral administration of the leaves aqueous extract of M. micrantha produced significant and dose dependant increase in faeces output of rats in regards to the accumulation of water in intestinal loop and the stimulation of gastrointestinal motility. These effects were similar with that of castor oil (standard drug) at high dose of 400 mg/kg. Castor oil affects electrolyte transport and smooth muscle contractility in the intestine [18]. Its cathartic action is due to water accumulation in the intestine [19]. Castor oil causes diarrhea due to its active metabolite ricinoleic acid [20] which stimulates peristaltic activity in the small intestine, leading to changes in the electrolyte permeability of the intestinal mucosa. Its action also stimulates the release of endogenous prostaglandin [21]. The observed activities therefore suggest that laxative activity of the aqueous extract of M. micrantha may be mediated through this mechanism of action of ricinoleic acid.

In the other hand, our results have indicated that M. micrantha and sodium picosulfate exert respectively opposite effects with loperamide on the gastrointestinal function. It is well documented that loperamide abolishes experimental osmotic diarrhea by acting on intestinal motility, and consequently reducing the flow entering the colon [22,23]. Sodium picosulfate is a member of the polyphenolic group of stimulant laxatives. Following oral administration, it is converted in the colon to an active form through the action of bacterial enzymes [24]. As a result, its effects are directed principally in the colon, where it stimulates peristalsis and, in common with other laxatives, reduces water reabsorption leading to the softening of stools. These results suggest that the aqueous extract of M. micrantha contains secondary metabolites which could act by this way.

This study has also shown that M. micrantha had stimulated Na+, K+ and Cl- secretion. Most of the naturally laxative exert their effects on the colonic epithelium by stimulating Cl- secretion and/or inhibiting Na+ absorption, resulting in an accumulation of fluid and subsequent increased colonic motility [25].

The results showed that the aqueous extract of M. micrantha increased the propulsion of charcoal meal. This result is in concordance with the findings of Traoré et al.[26] who have shown that the leaves aqueous extract of M. micrantha caused stimulant effects on the spontaneous motility of isolated rabbit ileum. In the other hand, Tsaï et al. [10] have put in evidence the presence of cholinergic active ingredients in the aqueous extract of M. micrantha using the longitudinal muscle of isolated guinea-pig ileum. The propulsion of charcoal meal is probably due to the increasing of peristaltic movement in rat gastrointestinal tract resulting from the stimulation of cholinergic receptors by M. micrantha.

The intestinal transit is controlled by both neural and myogenic mechanisms [27]. An increase of the contractile activity of the smooth layers in general is responsible for acceleration of intestinal propulsion. Several mediators and neurotransmitters govern these motor patterns. Acethylcholine is the main excitatory neurotransmitter in the enteric nervous system [28]. Thus the presence of cholinomimetic constituents in the plant extract can explain the usefulness of M. micrantha in constipation pointed out by the ethnobotanical informations [7].

The Presence of phytoconstituents like terpenoids, sterols, flavonoids, phenolic compounds, tannins and alkaloids [29] have been previously found to be responsible for laxative activities in plants. Phytochemical screening of the extract of M. micrantha revealed the presence of alkaloids, tannins, flavonoids, polyphenols, sterols and polyterpenes. These constituents may be responsible for the laxative activity of M. micrantha.

Conclusions

This study has shown that M. micrantha has laxative effects in addition to the various physiological effects earlier reported by other authors. The results of this study justify the use of the leaves of M. micrantha as laxative in traditional medicine. Further studies may be directed at characterizing the bioactive ingredients that are responsible for the observed activity in the plant.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SM carried out the laboratory studies, helped in analysis of data and preparation of manuscript. CB collected the plant material, obtained a voucher specimen and made substantial contributions to data acquisition. DY helped in the animal experiments and statistical analysis. AJD has been involved in revising the manuscript. JDN and YJD have been involved in acquisition, analysis and interpretation of data, revising the manuscript for substantial intellectual content and final approval of manuscript for submission. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:

http://www.biomedcentral.com/1472-6882/10/7/prepub

Contributor Information

Souleymane Méité, Email: souley_ci@yahoo.fr.

Calixte Bahi, Email: bahi1calixte@yahoo.fr.

Dodéhé Yéo, Email: dodeheyeo@yahoo.fr.

Jacques Y Datté, Email: yaodj@ci.refer.org.

Joseph A Djaman, Email: djamanj@yahoo.fr.

David J N'guessan, Email: nguessanjd@yahoo.fr.

Acknowledgements

The authors are indebted to Professor Aké-Assi Laurent (Laboratory of Botany, Unité de Formation et de Recherche -Biosciences, University of Cocody-Abidjan, Côte d'Ivoire) for botanical identification of Mareya micrantha (Benth.) Müll. Arg. (Euphorbiaceae).

References

  1. Muller-Lissner S. The patholophysiology, diagnosis and treatment of constipation. Dtsch Artztebl Int. 2009;106:424–432. doi: 10.3238/arztebl.2009.0424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750–759. doi: 10.1111/j.1572-0241.2004.04114.x. [DOI] [PubMed] [Google Scholar]
  3. Bosshard W, Dreher R, SChnegg JF, Bula CJ. The treatment of chronic constipation in elderly people: an update. Drugs Aging. 2004;21:911–930. doi: 10.2165/00002512-200421140-00002. [DOI] [PubMed] [Google Scholar]
  4. Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective. Aliment Pharmacol Ther. 2007;25:599–608. doi: 10.1111/j.1365-2036.2006.03238.x. [DOI] [PubMed] [Google Scholar]
  5. Bengtsson M, Ohlsson B. Psychological well-being and symptoms in women with chronic constipation treated with sodium picosulphate. Gastroenterol Nurs. 2005;28:3–12. doi: 10.1097/00001610-200501000-00002. [DOI] [PubMed] [Google Scholar]
  6. N'guessan K. Thèse de Doctorat 3ème cycle. Université d'Abidjan-Cocody, Botanique et biologie végétale; 1995. Contribution à l'étude ethnobotanique chez les Krobou de la souspréfecture d'Agboville (Côte d'Ivoire) [Google Scholar]
  7. Mac Foy CA, Cline EI. In vitro antibacterial activities of three plants used in traditional medicine in Sierra Leone. J Ethnopharmacol. 1990;28:323–327. doi: 10.1016/0378-8741(90)90083-6. [DOI] [PubMed] [Google Scholar]
  8. Guede-guina F, Tsai CS, Smith MO, Vangah MM, Washington B, Ochillo RF. The use of isoleted functional heart to pharmacologically characterize active ingredient in the aqueous extracts of Mareya micrantha. J Ethnopharmacol. 1995;45:19–26. doi: 10.1016/0378-8741(94)01190-B. [DOI] [PubMed] [Google Scholar]
  9. Abo KJ-C, Aka KJ, Ehile EE, Guede Guina F, Traore F. Effets cholinergiques d'un extrait aqueux brut de Mareya micrantha (Euphorbiacée) sur la pression et d'activité cardiaque. Revue Med Pharm Afr. 2000;5:11–20. [Google Scholar]
  10. Tsai CS, Guede Guina F, Smith MO, Vangah MM, Ochillo RF. Isolation of cholinergic active ingredients in aqueouse extracts of Mareya micrantha using the longitudinal muscle of isolated guinea-pig ileum as a pharmacological activity marker. J Ethnopharmacol. 1995;45:215–222. doi: 10.1016/0378-8741(94)01219-P. [DOI] [PubMed] [Google Scholar]
  11. Zirihi GN, Mambu L, Guédé-Guina F, Bodo B, Grellier P. In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for the treatment of malaria. J Ethnopharmacol. 2005;98:281–285. doi: 10.1016/j.jep.2005.01.004. [DOI] [PubMed] [Google Scholar]
  12. Silva GL, Lee I, Kinghorn AD. In: Methods in Biotechnology (Natural product Isolation) Cannell RJP, editor. New Jersey: Humana press; 1998. Special problems with the extraction of plants; pp. 343–363. full_text. [Google Scholar]
  13. Mascolo N, Izzo AA, Avtore G, Barboto F, Capasso F. Nitric oxide and castor oil induced diarrhea. J Pharmacol Exp Therap. 1994;268:291–295. [PubMed] [Google Scholar]
  14. Robert A, Nezamis JE, Lancaster C, Hanchar AJ, Klepper MS. Enteropooling assay, a test for diarrhea produced by prostaglandins. Prostaglandins. 1976;11:809–828. doi: 10.1016/0090-6980(76)90189-1. [DOI] [PubMed] [Google Scholar]
  15. Pazhani GP, Subramanian N, Arunchalam G, Hemalatha S, Ravichandran V. Antidiarrheal potencial of Elephantopus Scaber Linn leaf extract. Ind drugs. 2001;38:269–271. [Google Scholar]
  16. Capasso F, Mascolo N, Autore G, Romano V. Laxatives and the production of autacoids by rat colon. J pharm Pharmacol. 1986;38:627–629. doi: 10.1111/j.2042-7158.1986.tb03097.x. [DOI] [PubMed] [Google Scholar]
  17. Takaharu S, Fujie M, Yuji L, Kouji M, Hideo K. Laxative and Antidiarrheal activity of polycarbophil in mice and rats. Jpn J Pharmacol. 2002;89:133–141. doi: 10.1254/jjp.89.133. [DOI] [PubMed] [Google Scholar]
  18. Izzo AA, Mascolo N, Viola P, Capasso F. Inhibitors of nitric oxide synthase enhance rat ileum contractions induced by ricinoleic acid in vitro. Eur J Pharmacol. 1993;243:87–90. doi: 10.1016/0014-2999(93)90172-E. [DOI] [PubMed] [Google Scholar]
  19. Chitme HR, Chandra R, Kaushik S. Studies on Antidiarrheal activity on calotropis gigantean in experimental animals. J Pharm Pharmaceut Sci. 2004;7:70–75. [PubMed] [Google Scholar]
  20. Ammon HV, Thomas PJ, Phillips SF. Effect of the oleic acid and ricinoleic acid net jejunal water and electrolyte movement. J Clin Invest. 1974;53:374–379. doi: 10.1172/JCI107569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Galvez J, Zavzuelo A, Crespo ME, Lorente MD, Ocete MA, Jimenez J. Anti-diarrhoeic activity of Euphorbia hirta extract and isolation of an active flavonoid constituent. Planta Med. 1993;59:333–336. doi: 10.1055/s-2006-959694. [DOI] [PubMed] [Google Scholar]
  22. Hughes S, Higgs NB, Turnberg LA. Loperamide has antisecretory activity in the human jejunum in vivo. Gut. 1984;25:931–935. doi: 10.1136/gut.25.9.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lawrence RS, Carol ASA, Stephen GM, John SF. Mechanism of the Antidiarrheal effect of loperamide. Gastroenterology. 1984;86:1475–1480. [PubMed] [Google Scholar]
  24. Kim DH, Hyun SH, Shim SB, Kobashi K. The rôle of intestinal bacteria in the transformation of sodium picosulphate. Jpn J Pharmacol. 1992;59:1–5. doi: 10.1254/jjp.59.1. [DOI] [PubMed] [Google Scholar]
  25. Chatsri D, Sutthasinee P, Watchareewan T, Nateetip K. Barakol Extracted from Cassia Siamea stimulates chloride secretion in rat colon. J pharmacol Exp Ther. 2005;314:732–734. doi: 10.1124/jpet.105.084210. [DOI] [PubMed] [Google Scholar]
  26. Traoré F, Dosso M, Guede-Guede F, Aka KJ. Effet myostimulant d'un extrait aqueux de Mareya micrantha (Euphorbiaceae) sur l'activité contractile intestinale de lapin. Ethnopharmacologie. 2004;33:45–59. [Google Scholar]
  27. Huizinga JD, Ambrous K, Der-Silaphet T. Cooperation between neural and myogenic mechanisms in the control of distension-induced peristalsis in the mouse small intestine. J Physiol. 1998;506:843–56. doi: 10.1111/j.1469-7793.1998.843bv.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Waterman SA, Costa M. The role of enteric inhibitory motoneurons in peristalsis in the isolated guinea-pig small intestine. J Physiol. 1994;477:459–468. doi: 10.1113/jphysiol.1994.sp020207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Longanga-Otshudi A, Vercruysse A, Foriers A. Contribution to the ethnobotanical, phytochemical and pharmacological studies of traditionally used medicinal plants in the treatment of dysentery and diarrhea in Lomela area, Democratic Republic of Congo (DRC) J Ethnopharmacol. 2000;71:411–423. doi: 10.1016/S0378-8741(00)00167-7. [DOI] [PubMed] [Google Scholar]

Articles from BMC Complementary and Alternative Medicine are provided here courtesy of BMC

RESOURCES